21Dec 2022
Maintenance dienogest therapy following adjuvant gonadotropin‐releasing hormone agonist treatment after uterus‐sparing surgery in adenomyosis: A retrospective cohort study

Maintenance dienogest therapy following adjuvant gonadotropin‐releasing hormone agonist treatment after uterus‐sparing surgery in adenomyosis: A retrospective cohort study

To investigate the safety and efficacy of adjuvant gonadotropin‐releasing hormone agonist (GnRH‐a) treatment followed by maintenance dienogest (DNG) therapy after uterus‐sparing surgery. The symptom recurrence rate was significantly lower in the maintenance group than in the control group. The findings of this study suggest that combinatorial treatment with GnRH‐a (adjuvant treatment) and DNG (maintenance therapy) represents a safe and effective short‐term therapy after uterus‐sparing surgery for adenomyosis.

  • #gynaecology - ivf

Like

Save

Share